Suzetrigine
VX24-548-111
Phase 3 small_molecule active
Quick answer
Suzetrigine for Diabetic Peripheral Neuropathic Pain is a Phase 3 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Diabetic Peripheral Neuropathic Pain
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active